Amicus Therapeutics, Inc.FOLDNASDAQ
LOADING
|||
Operating Income Scaling
Trending higher, above historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$24.88M
↑ 112% above average
Average (9y)
$-210.50M
Historical baseline
Range
High:$24.88M
Low:$-441.99M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $24.88M | +132.2% |
| 2023 | $-77.21M | +63.6% |
| 2022 | $-212.12M | -2.8% |
| 2021 | $-206.43M | +16.4% |
| 2020 | $-247.00M | +18.8% |
| 2019 | $-304.04M | +7.5% |
| 2018 | $-328.78M | +25.6% |
| 2017 | $-441.99M | -143.0% |
| 2016 | $-181.89M | -39.4% |
| 2015 | $-130.44M | - |